Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 27 | $12,196,034 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 1,587 | 330.5356 | 524,560 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 2,759 | 331.3594 | 914,221 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 2,382 | 332.3785 | 791,726 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 800 | 333.6575 | 266,926 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 200 | 334.97 | 66,994 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 1,951 | 322.4498 | 629,100 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 1,649 | 323.4651 | 533,394 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 900 | 324.6867 | 292,218 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 800 | 325.6263 | 260,501 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 1,000 | 327.6268 | 327,627 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 400 | 328.6812 | 131,472 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 967 | 329.8601 | 318,975 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 75 | 330.225 | 24,767 | D |
| 05 Dec 2024 16:46 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 03 Dec 2024 | Sale | 3,080 | 315.2116 | 970,852 | I |
| 05 Dec 2024 16:46 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 03 Dec 2024 | Sale | 520 | 315.9038 | 164,270 | I |
| 27 Nov 2024 16:16 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 25 Nov 2024 | Sale | 2,200 | 350.0775 | 770,170 | I |
| 27 Nov 2024 16:16 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 25 Nov 2024 | Sale | 1,200 | 350.7146 | 420,858 | I |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,000 | 218.9945 | 218,994 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 100 | 219.9 | 21,990 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,100 | 217.8553 | 239,641 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 721 | 216.9838 | 156,445 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,804 | 214.6815 | 387,285 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 375 | 216.0836 | 81,031 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 2,190 | 213.8548 | 468,342 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,363 | 212.8513 | 290,116 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 5,009 | 211.844 | 1,061,127 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 8,827 | 210.9926 | 1,862,432 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)